Spero Therapeutics, Inc.

Contributing Author

Recent Articles by Spero Therapeutics, Inc.

May-28	Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee SPRO GlobeNewswire
May-13	Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update SPRO GlobeNewswire
May-05	Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025 SPRO GlobeNewswire